All data are based on the daily closing price as of May 12, 2026
h
Hanmi Science Co.
008930.KO
24.35 USD
0.42
+1.76%
Overview
Last close
24.35 usd
Market cap
1.65B usd
52 week high
37.55 usd
52 week low
17.04 usd
Target price
21.72 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.8114
Price/Book Value
2.6118
Enterprise Value
1.74B usd
EV/Revenue
1.915
EV/EBITDA
16.9778
Key financials
Revenue TTM
910.18M usd
Gross Profit TTM
208.81M usd
EBITDA TTM
44.57M usd
Earnings per Share
N/A usd
Dividend
0.2 usd
Total assets
1.03B usd
Net debt
59.56M usd
About
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.